BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 4359964)

  • 1. Defective superoxide production by granulocytes from patients with chronic granulomatous disease.
    Curnutte JT; Whitten DM; Babior BM
    N Engl J Med; 1974 Mar; 290(11):593-7. PubMed ID: 4359964
    [No Abstract]   [Full Text] [Related]  

  • 2. Editorial: Superoxide radical and the bactericidal action of phagocytes.
    Fridovich I
    N Engl J Med; 1974 Mar; 290(11):624-5. PubMed ID: 4591067
    [No Abstract]   [Full Text] [Related]  

  • 3. Abnormal bactericidal, metabolic, and lysosomal functions of Chediak-Higashi Syndrome leukocytes.
    Root RK; Rosenthal AS; Balestra DJ
    J Clin Invest; 1972 Mar; 51(3):649-65. PubMed ID: 4400956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological defense mechanisms. The effect of bacteria and serum on superoxide production by granulocytes.
    Curnutte JT; Babior BM
    J Clin Invest; 1974 Jun; 53(6):1662-72. PubMed ID: 4364409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative aspects of the production of superoxide radicals by phagocytizing human granulocytes.
    Weening RS; Wever R; Roos D
    J Lab Clin Med; 1975 Feb; 85(2):245-52. PubMed ID: 163283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Letter: Leukocyte superoxide in chronic granulomatous disease.
    Saccoccia P
    N Engl J Med; 1974 Jun; 290(23):1328. PubMed ID: 4827638
    [No Abstract]   [Full Text] [Related]  

  • 7. [Chronic granulomatous disease. Clinical symptoms and biochemical background].
    Weening RS; Kollee LA; van Gool JD; Roos D
    Ned Tijdschr Geneeskd; 1976 Aug; 120(35):1480-7. PubMed ID: 184401
    [No Abstract]   [Full Text] [Related]  

  • 8. The role of superoxide anion generation in phagocytic bactericidal activity. Studies with normal and chronic granulomatous disease leukocytes.
    Johnston RB; Keele BB; Misra HP; Lehmeyer JE; Webb LS; Baehner RL; RaJagopalan KV
    J Clin Invest; 1975 Jun; 55(6):1357-72. PubMed ID: 166094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological defense mechanisms. The production by leukocytes of superoxide, a potential bactericidal agent.
    Babior BM; Kipnes RS; Curnutte JT
    J Clin Invest; 1973 Mar; 52(3):741-4. PubMed ID: 4346473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the pathogenesis of chronic granulomatous disease. 2. Impaired activation of glucose-6-phosphate dehydrogenase in leukocytes of a patient with chronic granulomatous disease during phagocytosis.
    Usui T; Shimizu B; Amano D; Ishibashi S; Murakami K
    Hiroshima J Med Sci; 1971 Dec; 20(4):245-53. PubMed ID: 5149957
    [No Abstract]   [Full Text] [Related]  

  • 11. Pyridine nucleotide-dependent superoxide production by a cell-free system from human granulocytes.
    Babior BM; Curnutte JT; Kipnes BS
    J Clin Invest; 1975 Oct; 56(4):1035-42. PubMed ID: 239968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal kinetics of degranulation in chronic granulomatous disease.
    Gold SB; Hanes DM; Stites DP; Fudenberg HH
    N Engl J Med; 1974 Aug; 291(7):332-7. PubMed ID: 4850362
    [No Abstract]   [Full Text] [Related]  

  • 13. Disorders of phagocyte function: biochemical aspects.
    Quie PG
    Prog Clin Biol Res; 1977; 13():157-69. PubMed ID: 45476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic granulomatous disease--pieces of a cellular and molecular puzzle.
    Karnovsky ML
    Fed Proc; 1973 Apr; 32(4):1527-33. PubMed ID: 4144970
    [No Abstract]   [Full Text] [Related]  

  • 15. Defect in pyridine nucleotide dependent superoxide production by a particulate fraction from the granulocytes of patients with chronic granulomatous disease.
    Curnutte JT; Kipnes RS; Babior BM
    N Engl J Med; 1975 Sep; 293(13):628-32. PubMed ID: 239342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Normal and defective phagocytosis. Theory, clinical aspects and laboratory diagnosis.
    Hitzig WH
    Triangle; 1973; 12(2):57-67. PubMed ID: 4583529
    [No Abstract]   [Full Text] [Related]  

  • 17. Altered levels of glucose-6-phosphate dehydrogenase stabilizing factors in X-linked chronic granulomatous disease.
    Erickson RP; Stites DP; Fudenberg HH; Epstein CJ
    J Lab Clin Med; 1972 Nov; 80(5):644-53. PubMed ID: 4404227
    [No Abstract]   [Full Text] [Related]  

  • 18. Phagocytosis in chronic granulomatous disease and the Chediak-Higashi syndrome.
    Stossel TP; Root RK; Vaughan M
    N Engl J Med; 1972 Jan; 286(3):120-3. PubMed ID: 5007151
    [No Abstract]   [Full Text] [Related]  

  • 19. The mechanism of bacterial killing by normal and chronic granulomatous disease leukocytes.
    Johnston RB
    Birth Defects Orig Artic Ser; 1975; 11(1):71-2. PubMed ID: 167886
    [No Abstract]   [Full Text] [Related]  

  • 20. [Description of a case of infantile chronic granulomatous disease on a granulocytopathic base].
    Meroni R; D'Amico E
    Minerva Pediatr; 1977 May; 29(17):1135-40. PubMed ID: 875995
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.